The trademark DOLYSAN was filed by PHARMALINK,S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on July 13, 2021, and received one opposition filed on September 8, 2021 by Sanofi Mature IP on Likelihood of confusion. the opponent was represented by DENNEMEYER & ASSOCIATES and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 8, 2021
The application was filed in Spanish, and Spanish was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003154454 was refused according to Article 8(1)(b) EUTMR with decision issued on April 3, 2023 by the EUIPO.